Daniel H. Orenstein Health Catalyst, Inc. (HCAT) insider trading activity

Daniel H. Orenstein is General Counsel of Health Catalyst, Inc.. Currently has a direct ownership of 133,097 shares of HCAT, which is worth approximately $918,369. The most recent transaction as insider was on Mar 01, 2023, when has been sold 2,186 shares (Common Stock) at a price of $14.29 per share, resulting in proceeds of $31,237. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 133K

0% 3M change

0% 12M change

Total Value Held $918,369

Daniel H. Orenstein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2023	SELL Payment of exercise price or tax liability	$31,237 $14.29 p/Share	2,186 Reduced 1.62%	133,097 Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	40,000 Added 22.82%	135,283 Common Stock
Dec 01 2022	SELL Payment of exercise price or tax liability	$46,061 $10.65 p/Share	4,325 Reduced 4.34%	95,283 Common Stock
Sep 06 2022	SELL Open market or private sale	$31,984 $11.27 p/Share	2,838 Reduced 2.77%	99,608 Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$14,222 $11.61 p/Share	1,225 Reduced 1.18%	102,446 Common Stock
Jun 06 2022	SELL Open market or private sale	$42,144 $14.85 p/Share	2,838 Reduced 2.66%	103,671 Common Stock
Jun 01 2022	SELL Payment of exercise price or tax liability	$17,870 $14.6 p/Share	1,224 Reduced 1.14%	106,509 Common Stock
Apr 27 2022	BUY Exercise of conversion of derivative security	$51,700 $10.34 p/Share	5,000 Added 4.44%	107,733 Common Stock
Mar 03 2022	SELL Open market or private sale	$110,284 $26.82 p/Share	4,112 Reduced 3.85%	102,733 Common Stock
Mar 02 2022	SELL Payment of exercise price or tax liability	$6,779 $26.69 p/Share	254 Reduced 0.24%	106,845 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$41,490 $26.63 p/Share	1,558 Reduced 1.46%	105,238 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	1,861 Added 1.71%	107,099 Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	-	40,000 Added 27.25%	106,796 Common Stock
Dec 06 2021	SELL Open market or private sale	$176,332 $38.06 p/Share	4,633 Reduced 6.49%	66,796 Common Stock
Dec 03 2021	SELL Open market or private sale	$107,175 $42.87 p/Share	2,500 Reduced 3.38%	71,429 Common Stock
Dec 03 2021	BUY Exercise of conversion of derivative security	$25,850 $10.34 p/Share	2,500 Added 3.27%	73,929 Common Stock
Dec 02 2021	SELL Payment of exercise price or tax liability	$172,708 $41.95 p/Share	4,117 Reduced 5.45%	71,429 Common Stock
Nov 01 2021	SELL Open market or private sale	$134,525 $53.81 p/Share	2,500 Reduced 3.2%	75,546 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$25,850 $10.34 p/Share	2,500 Added 3.1%	78,046 Common Stock
Oct 01 2021	SELL Open market or private sale	$123,025 $49.21 p/Share	2,500 Reduced 3.2%	75,546 Common Stock
Oct 01 2021	BUY Exercise of conversion of derivative security	$25,850 $10.34 p/Share	2,500 Added 3.1%	78,046 Common Stock
Sep 03 2021	SELL Open market or private sale	$209,241 $54.32 p/Share	3,852 Reduced 4.85%	75,546 Common Stock
Sep 03 2021	BUY Exercise of conversion of derivative security	$25,850 $10.34 p/Share	2,500 Added 3.05%	79,398 Common Stock
Sep 01 2021	SELL Payment of exercise price or tax liability	$62,256 $54.23 p/Share	1,148 Reduced 1.47%	76,898 Common Stock
Aug 02 2021	SELL Open market or private sale	$145,100 $58.04 p/Share	2,500 Reduced 3.1%	78,046 Common Stock

DHO

Daniel H. Orenstein

General Counsel

South Jordan, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCAT shares.

Notify only if

Value

Insider Trading

Get notified when an Health Catalyst, Inc. insider buys or sells HCAT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Health Catalyst, Inc.

Track Activities on HCAT

Account